Overview

Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Chronic Granulomatous Disease(CGD)

Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
In this study the investigators plan to use optimal busulfan dose through pharmacokinetic study in stem cell transplantation of CGD patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Busulfan